<p class="MsoNormal">In March, Pfizer/BioNTech released data that showed its vaccine is 100% effective at stopping COVID-19 in people ages 12 to 15, setting the stage for the US Food and Drug Administration to expand its emergency use authorization to younger teenagers.</p>
